[
  {
    "ts": null,
    "headline": "Is Bristol Myers Squibb (BMY) Pricing Look Attractive After Recent Share Price Climb",
    "summary": "If you are wondering whether Bristol-Myers Squibb is offering good value right now, this article will walk through what the current share price could mean for long term investors. The stock last closed at US$62.37, with returns of 2.8% over 7 days, 14.9% over 30 days, 16.7% year to date, 9.9% over 1 year, 3.2% over 3 years, and 25.9% over 5 years. Recent news coverage has continued to focus on Bristol-Myers Squibb as a major player in large cap pharmaceuticals, including ongoing attention on...",
    "url": "https://finnhub.io/api/news?id=af0d2f329d65ba092f0962a14bbfa600d911df7d1ffb6ead19582d5ddb3f18b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772320309,
      "headline": "Is Bristol Myers Squibb (BMY) Pricing Look Attractive After Recent Share Price Climb",
      "id": 139266721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "If you are wondering whether Bristol-Myers Squibb is offering good value right now, this article will walk through what the current share price could mean for long term investors. The stock last closed at US$62.37, with returns of 2.8% over 7 days, 14.9% over 30 days, 16.7% year to date, 9.9% over 1 year, 3.2% over 3 years, and 25.9% over 5 years. Recent news coverage has continued to focus on Bristol-Myers Squibb as a major player in large cap pharmaceuticals, including ongoing attention on...",
      "url": "https://finnhub.io/api/news?id=af0d2f329d65ba092f0962a14bbfa600d911df7d1ffb6ead19582d5ddb3f18b6"
    }
  }
]